Skip to main content
. 2020 Jul 3;24:100617. doi: 10.1016/j.ymgmr.2020.100617

Table 1.

Initial presentation.

Patient Sex Mutations Age of Onset Age at Dx Brain MRI Biochemical Investigations Enzyme Activity (Fibroblasts) Developmental Delay Regression Seizures Dystonia Visual Impairment Hearing Loss Cardiomyopathy GT Feedings Clinical Course
HIBCH 1 M c.196C > T p.(Arg66Trp) c.196C > T p.(Arg66Trp) 5 m 13 y Leigh's Normal lactate and PDHC ↑ C4OH Yes Yes No Yes Yes No No Yes Severe, progressive
2 F c.196C > T p.(Arg66Trp) c.196C > T p.(Arg66Trp) 6 m 12 y Leigh's Normal lactate, ↑ C4OH Yes Yes No Yes Yes No No Yes Severe, progressive
ECHS1 3 M c.832G > A p.(Ala278Thr) c.489G > A p.(Pro163=) 15 m 6 y Leigh's Intermittent lactic acidosis & ketosis Yes Yes No Yes Yes No No Yes Severe, progressive
4 M c.832G > A p.(Ala278Thr) c.489G > A p.(Pro163=) 6 m 13 y Leigh's Intermittent lactic acidosis & ketosis Yes Yes No Yes Yes No No No Moderate, progressive
5 M c.849_852del p.(Lys284Profs*31) c.713C > T p.(Ala238Val) 11 m 3 y Leigh's Intermittent lactic acidosis & ketosis ND Yes Yes Yes Yes Yes Yes No Yes Severe, progressive

PDHC: Pyruvate dehydrogenase complex, ND: Not done